Stephen Willey analyst STIFEL

Currently out of the existing stock ratings of Stephen Willey, 156 are a BUY (71.56%), 60 are a HOLD (27.52%), 2 are a SELL (0.92%).

Stephen Willey

Work Performance Price Targets & Ratings Chart

Analyst Stephen Willey works at STIFEL with a stock forecast success ratio of 47.64% fulfilled within 176.2 days on average.

Stephen Willey’s has documented 394 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NRIX, Nurix Therapeutics  at 15-May-2024.

Wall Street Analyst Stephen Willey

Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $21 was fulfilled within 1 day with a profit of $4.15 (16.5%) receiving and performance score of 165.01.

Average potential price target upside

ADGI Adagio Therapeutics AKAO Achaogen AVEO AVEO Pharmaceuticals CNAT Conatus Pharmaceuticals DRNA Dicerna Pharmaceuticals EXEL Exelixis GNCA Genocea Biosciences IGMS IGM Biosciences INCY yte INO Inovio Pharmaceuticals ITMN InterMune LXRX Lexicon Pharmaceuticals MGNX MacroGenics MTEM Molecular Templates NKTX Nkarta  NLNK NewLink Genetics NRIX Nurix Therapeutics  ONCE Spark Therapeutics RLYP Relypsa SBTX Silverback Therapeutics  SGEN Seagen SQZ Sqz Biotechnologies Co ZYME Zymeworks . Common Stock AKCA Akcea Therapeutics ALXN Alexion Pharmaceuticals CGEN Compugen GLYC GlycoMimetics MEIP MEI Pharma BCEL Atreca BMRN Biomarin Pharmaceutical LUMO Lumos Pharma BOLT Bolt Biotherapeutics HSTO Histogen IMGO Imago Biosciences TTPH Tetraphase Pharmaceuticals INSM Insmed ALNY Alnylam Pharmaceuticals CMPX Compass Therapeutics . CUE Cue Biopharma GERN Geron ISEE IVERIC bio PRTO Proteon Therapeutics VOR Vor Biopharma XFOR X4 Pharmaceuticals IONS Ionis Pharmaceuticals XENE Xenon Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

5

$1.52 (43.68%)

9

2 years 13 days ago

1/3 (33.33%)

$2.28 (83.82%)

2

Sell

6

2 years 4 months 13 days ago

3/4 (75%)

$-0.12 (-1.96%)

12

Hold

2 years 4 months 28 days ago

0/1 (0%)

$26.16 (77.30%)

Buy

40

2 years 5 months 10 days ago

1/1 (100%)

$6.16 (18.20%)

3

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Stephen Willey is most bullish on?

Potential upside of $23.63 has been obtained for XENE (XENON PHARMACEUTICALS)

Which stock is Stephen Willey is most reserved on?

Potential downside of $1.56 has been obtained for CGEN (COMPUGEN)

What Year was the first public recommendation made by Stephen Willey?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?